Glucose metabolism in outpatients with new-onset hypertension in chinese han population

Clinical and Experimental Hypertension

Volumn 34, Issue 7, 2012, Pages 474-481

  Gu, Ping ^a   Jiang, Weimin ^b   Cheng, Maowei ^a   Lu, Bin ^a   Shao, Jiaqing ^a   Du, Hong ^a   Jiang, Shisen ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Abnormal glucose metabolism; Diabetes mellitus; Insulin resistance; New onset hypertension

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGING; ARTICLE; CHINESE; DIET RESTRICTION; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OUTPATIENTS; PREDIABETIC STATE; PREVALENCE; SEX FACTORS;

EID: 84870447659     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.666601     Document Type: Article

References (27)

1. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37(4):1053-1059.
2. Korhonen P, Aarnio P, Saaresranta T, et al. Glucose homeostasis in hypertensive subjects. Hypertension 2008; 51(4):945-949.
3. Turner R, Holman R, Stratton I, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317(7160):703-713.
4. Jandeleit-Dahm KA, Tikellis C, Reid CM, et al. Why blockade of the renin-angiotensin system reduces the incidence of newonset diabetes. J Hypertens 2005; 23(3):463-473.
5. Yagi S, Goto S, Yamamoto T, et al. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension. Hypertens Res 2003; 26(5):383-387.
6. Takada M, Ura N, Higashiura K, et al. Effects of cilnidipine on muscle fiber composition, capillary density and muscle blood flow in fructose-fed rats. Hypertens Res 2001; 24(5): 565-572.
7. Inukai T, Inukai Y, Matsutomo R, et al. Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism. J Int Med Res 2004; 32(2):206-213.
8. Giorda C, Appendino M. Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 1993; 42(11):1440-1442.
9. Lithell HO. Hyperinsulinemia, insulin resistance, and the treatment of hypertension. Am J Hypertens 1996; 9(11): 150S-154S.
10. Williams WR, Schneider KA, Borhani NO, et al. The relationship between diuretics and serum cholesterol in hypertension detection and follow-up program participants. Am J Prev Med 1986; 2(5):248-255.
11. Mancia G, Volpe R, Boros S, et al. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004; 22(1):51-57.
12. Garcia-Puig J, Ruilope LM, Luque M, et al. Glucose metabolism in patients with essential hypertension. Am J Med 2006; 119(4):318-326.
13. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7):412-419.
14. Baskar V, Kamalakannan D, Holland MR, et al. The prevalence of hypertension and utilization of antihypertensive therapy in a district diabetes population. Diabetes Care 2002; 25(11):2107-2108.
15. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004; 291(3): 335-342.
16. Salmasi AM, Alimo A, Dancy M. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic. Am J Hypertens 2004; 17(6):483-488.
17. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362(12): 1090-1101.
18. Sowers Jr. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004; 286(5):H1597-H1602.
19. Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med 2006; 23(10):1130-1135.
20. Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008; 51(3): 264-270.
21. Chen YX, Wang XQ, Wang JF, et al. Glucometabolic state of in-hospital patients with primary hypertension in subpopulation of partial regions in China. J Hum Hypertens 2008; 22(5):346-351.
22. Nilsson PM, Cifkova R, Kjeldsen SE, et al. European Society of Hypertension Scientific Newsletter: update on hypertension management: prevention of type 2 diabetes mellitus with antihypertensive drugs. J Hypertens 2006; 24(12): 2478-2482.
23. Messerli FH, Grossman E, Leonetti G. Antihypertensive therapy and new onset diabetes. J Hypertens 2004; 22(10): 1845-1847.
24. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metabol 2000; 85(9):3101-3108.
25. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25(5):829-834.
26. McLaughlin T, Allison G, Abbasi F, et al. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004; 53(4):495-499.
27. Lonati C, Morganti A, Comarella L, et al. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. J Hypertens 2008; 26(9):1801-1808.